BELLUS Health, Inc. (NASDAQ: BLUS), a global health company, is committed to developing and commercializing products that provide innovative health solutions to address substantial, but unmet needs. The company’s wholly owned subsidiary, OVOS Natural Health Inc., aims to develop a strong franchise with several products marketed to help brain function as well as expand to other conditions. For further information, visit the Company’s web site at www.bellushealth.com.
- 17 years ago
QualityStocks
BELLUS Health, Inc. (NASDAQ: BLUS)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Featured in NetworkNewsWire Editorial on AI-Driven Breast Cancer Imaging
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) announced its inclusion in a NetworkNewsWire (“NNW”) editorial titled…
-
QualityStocksNewsBreaks – Forward Industries, Inc. (NASDAQ: FORD) Featured in Oak Ridge Financial Research Report Highlighting Transition to Solana Digital Asset Treasury Model
Forward Industries (NASDAQ: FORD) has been featured in a new research report by Oak Ridge…
-
QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Advances HyBryte(TM) as Potential First-Line CTCL Treatment with Promising FLASH Results
Soligenix (NASDAQ: SNGX) is continuing to build momentum in the treatment of early-stage cutaneous T-cell…